Author

Y. Harano

Observed names: Y HARANO, Y Harano, Y. HARANO, Yu HARANO

Institution: National Cerebral and Cardiovascular Center

Observed institutions: Koshien University, Shiga University of Medical Science, Shiga University, Keio University, Kyoto Pharmaceutical University, Osaka National Hospital, Keio University Hospital, MSD K.K. (Japan), National Cerebral and Cardiovascular Center, Kansai Rosai Hospital, Koga Hospital, Asanuma Corporation (Japan), Case Western Reserve University, The University of Osaka

OpenAlex ID: A5113629064

Glucose, Insulin and Somatostatin Infusion for the Determination of Insulin Sensitivity

1977 · Y. Harano, S. Ohgaku, et al. · The Journal of Clinical Endocrinology & Metabolism · 149

Phosphorylation of carnitine palmitoyltransferase and activation by glucagon in isolated rat hepatocytes

1985 · Y. Harano, A. Kashiwagi, et al. · FEBS Letters · 92

PDF

Direct automated assay method for serum or urine levels of ketone bodies

1985 · Y. Harano, M. Ohtsuki, et al. · Clinica Chimica Acta · 87

Sensitive and simplified method for the differential determination of serum levels of ketone bodies

1983 · Y. Harano, K. Kosugi, et al. · Clinica Chimica Acta · 77

Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo

1978 · Y. Harano, H. Hidaka, et al. · Metabolism · 75

Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects

1995 · Y. Harano, A. Kageyama, et al. · Metabolism · 72

Clinical Significance of Altered Insulin Sensitivity in Diabetes Mellitus Assessed by Glucose, Insulin, and Somatostatin Infusion

1981 · Y. HARANO, S. OHGAKU, et al. · The Journal of Clinical Endocrinology & Metabolism · 69

New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients

1986 · A Kashiwagi, Y Harano, et al. · Diabetes · 44

Ketone bodies as markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control

1984 · Y. Harano, K. Kosugi, et al. · Diabetologia · 38

PDF

Restenosis after Percutaneous Transluminal Coronary Angioplasty in Patients with Non-Insulin-Dependent Diabetes Mellitus (NIDDM)

1998 · Y. Asakura, M. Suzuki, et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 31

Mechanism of adrenergic stimulation of hepatic ketogenesis

1983 · K. Kosugi, Y. Harano, et al. · Metabolism · 27

Insulin Sensitivity in Pancreatitis, Liver Diseases, Steroid Treatment and Hyperthyroidism Assessed by Glucose, Insulin and Somatostatin Infusion

1984 · H. Yasuda, Y. Harano, et al. · Hormone and Metabolic Research · 24

Homozygous hypobetalipoproteinemia with spared chylomicron formation

1989 · Y. Harano, H. Kojima, et al. · Metabolism · 22

The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide

2000 · M. Takada, S. Fujita, et al. · European Journal of Clinical Pharmacology · 18

Development of Early Lesions of Microangiopathy in Chronically Diabetic Monkeys

1984 · H Yasuda, Y Harano, et al. · Diabetes · 17

Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys

1992 · Y. Harano, H. Kojima, et al. · Diabetes Research and Clinical Practice · 15

External pancreatic dysfunction associated with diabetes mellitus.

1978 · Y Harano, C I Kim, et al. · PubMed · 15

Structure and function of hepatic mitochondria in hemorrhage and endotoxemia.

1970 · R G DePalma, Y Harano, et al. · PubMed · 15

Improvement of Insulin Resistance in Essential Hypertension by Long-Acting Ca Antagonist Benidipine

1999 · M. Suzuki, A. Kanazawa, et al. · Clinical and Experimental Hypertension · 10

Chronically streptozocin-diabetic monkey does not closely mimic human diabetic neuropathy

1989 · H YASUDA, Y TANIGUCHI, et al. · Experimental Neurology · 10

Lipoprotein disorder in brain infarction and hemorrhage

1998 · A. Sato, Y. Asakura, et al. · International Journal of Clinical & Laboratory Research · 8

Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension

2000 · K. I. Ryomoto, M. Suzuki, et al. · American Journal of Hypertension · 7

Fatty Acid Oxidation, Citric Acid Cycle Activity, and Morphology of Mitochondria in Diabetic Rat Liver

1969 · Y. Harano, R. G. DePalma, et al. · Experimental Biology and Medicine · 7

Suppressive Effect of Vasopressin on Ketosis in Diabetic Rats

1992 · Aki Harano, H. Hidaka, et al. · Hormone and Metabolic Research · 6

Development of Specific and Non-Specific Somatostatin Analogs

1986 · T. Nakano, Y. Harano, et al. · Hormone and Metabolic Research · 6

Works count: 63

Citation count: 974

H-index: 15

I10-index: 20